United States· US:0310-1830_b78fbf2b-888c-41e2-bdab-cb5cd1ebb8fe
FASENRA
A benralizumab product containing benralizumab, registered in United States by AstraZeneca Pharmaceuticals LP. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Benralizumab is registered in 16 of 19 countries.
Countries holding a registration under ATC R03DX10 (benralizumab), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Benralizumab · ATC R03DX10
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BENRALIZUMAB
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Country
- United States (US)
- ATC code
- R03DX10
- ATC class
- Benralizumab
- Defined daily dose
- 0.54 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1103101830301 CARTRIDGE in 1 CARTON (0310-1830-30) / 1 mL in 1 CARTRIDGE
- ndc1103101830851 CARTRIDGE in 1 CARTON (0310-1830-85) / 1 mL in 1 CARTRIDGE
- ndc110310-1830-30
- ndc110310-1830-85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benralizumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFasenraOrifarm Oy
- NorwayFasenraAstraZeneca AB (2)
- Japanベンラリズマブ（遺伝子組換え）アストラゼネカ
- CzechiaFASENRAAstraZeneca AB, Södertälje
- SpainFASENRA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAstrazeneca Ab
- FranceFASENRA 30 mg, solution injectable en seringue préremplieASTRAZENECA AB
- United KingdomFasenra 30mg/1ml solution for injection pre-filled pensAstraZeneca UK Ltd
- IcelandFasenraAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fasenra
- Liechtenstein · Fasenra
- Norway · Fasenra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/76b9cb20-d666-4a7a-b2ad-5e900801697b GET /v1/drugs/76b9cb20-d666-4a7a-b2ad-5e900801697b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "30",
"substance": "BENRALIZUMAB",
"productndc": "0310-1830",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761070",
"marketing_category": "BLA"
}See everything about benralizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.